Regulatory Intelligence Reimagined
vi Regulatory Affairs Professionals Society
Alex May, MS
US Lead, Regulatory Policy
Genentech
Aleksandr Merenkov, PharmD, MS,
MBA, RAC-Drugs
Director, Global Regulatory Intelligence
Genmab US, Inc.
Kirsten Messmer, PhD, RAC-US
Owner
KM Intel LLC
Chelsea Miller, MA
Senior Consultant, Regulatory Affairs
The Bracken Group
Amin Osmani, MSc, MSc
CEO
Cedience Inc.
Brandy Proctor, MS
Regulatory Policy Manager
GSK
Amra Racic, MBA
VP Global Government Strategy
Veeva MedTech
Marco Rafael, PharmD, MBA
Policy Leader -PD Regulatory Science
F. Hoffmann-La Roche
Sean Schofield, PharmD, MS
Principal Regulatory Affairs Specialist
PPD clinical research business of
Thermo Fisher Scientific
Charity-Anne Metz Schuller,
PharmD, MSCR, RAC-US
Executive Director, Regulatory Affairs
and Head of Regulatory Intelligence
and Delivery
PPD clinical research business of
Thermo Fisher Scientific
Patterson Shafer
Managing Director
FTI Consulting
Eliza Shearer
Principal Regulatory Lead, Digital
Health Solutions
Convatec
Joshua S. Silverstein, PhD
Director, Regulatory Policy &
Intelligence Americas
Stryker
Lindsay Simon, RAC-Drugs
Senior Manager
3D Communications
Thomas Stover, PhD, MBA
Senior Director, Principal Consultant
Cencora, Global Consulting Services
US
Joseph M. Thomas, PhD
Regulatory Intelligence Lead
Moderna
Chris Whalley
Head of Global Regulatory Intelligence
and Analysis
Pfizer
Andrew C. Wingen, MS, RAC-Global
Director of Regulatory Policy
Bayer
Raya D. Zerger, MT(ASCP)SBB
Senior Staff, Legislative Initiatives,
Regulatory Affairs
Beckman Coulter, Inc.
Michelle Zucatti, MHA
Communications Executive
3D Communications